3-Tesla MRI Response to TACE in HCC (Liver Cancer)

NCT02057874 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Funding unavailable

Conditions

Adult Primary Hepatocellular Carcinoma
Advanced Adult Primary Liver Cancer
Localized Resectable Adult Primary Liver Cancer
Localized Unresectable Adult Primary Liver Cancer
Stage A Adult Primary Liver Cancer (BCLC)
Stage B Adult Primary Liver Cancer (BCLC)

Interventions

DEVICE: 3 Tesla Magnetic Resonance Imaging
DRUG: Magnevist® (Intravenous (IV) administration of MRI contrast agent)

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]